Japan's Pharma-Bio Industry Hosts $225 Million of COVID-Related Projects

Researched by Industrial Info Resources (Sugar Land, Texas)--To date, Japan has seen more than 628,000 confirmed COVID-19 cases, and more than 10,700…

Industrial Info | covid | IIR | pharmaceutical | Pharmaceutical & Biotech | manufacturing

Industrial Info

Tue May 11 2021

California's Biotech Industry Plans $5.3 Billion in Projects

Researched by Industrial Info Resources (Sugar Land, Texas)--California has one of the largest biotechnology clusters in the world. According to a report from the…

Industrial Info | covid | IIR | pharmaceutical | Pharmaceutical & Biotech

Industrial Info

Thu May 06 2021

COVID-19 Drives Demand for Active Pharmaceutical Ingredients (APIs) in North America

Researched by Industrial Info Resources (Sugar Land, Texas)--Pharmaceuticals and biological drugs are manufactured using ingredients usually produced offsite. Historically, the U.S. and Canada…

Industrial Info | covid | IIR | pharmaceutical | Pharmaceutical & Biotech | Capital Projects

Industrial Info

Thu Apr 29 2021

China's Pharmaceutical Capacity Remains Strong Despite COVID-Related Downturn

Researched by Industrial Info Resources (Sugar Land, Texas)--According to China's National Bureau of Statistics, in 2019, China's pharmaceutical capacity reached 2.769 million tons,…

Industrial Info | covid | IIR | pharmaceutical | Pharmaceutical & Biotech | Project Spending

Industrial Info

Wed Apr 21 2021

COVID-19 Pandemic Increases Demand for Vaccine Delivery Devices

Researched by Industrial Info Resources (Sugar Land, Texas)--As companies continue to develop vaccines to combat the pandemic, there is a growing need for needles,…

Industrial Info | covid | IIR | Pharmaceutical & Biotech | pharmaceutical | manufacturing

jwebb

Industrial Info

Thu Apr 08 2021

Japan's Pharma-Bio Industry Hosts $225 Million of COVID-Related Projects

Researched by Industrial Info Resources (Sugar Land, Texas)--To date, Japan has seen more than 628,000 confirmed COVID-19 cases, and more than 10,700 deaths. Although it has secured the largest amount of COVID-19 vaccines in Asia, Japan has inoculated only 2.2% of its population so far, the slowest among wealthy countries, according to Reuters. The government aims »

California's Biotech Industry Plans $5.3 Billion in Projects

Researched by Industrial Info Resources (Sugar Land, Texas)--California has one of the largest biotechnology clusters in the world. According to a report from the California Life Sciences Association (CLSA), this sector employed roughly 324,000 people and generated $6.4 billion in direct state and local taxes in 2020, with 1,350 new medicines in clinical trials, including COVID-19 »

COVID-19 Drives Demand for Active Pharmaceutical Ingredients (APIs) in North America

Researched by Industrial Info Resources (Sugar Land, Texas)--Pharmaceuticals and biological drugs are manufactured using ingredients usually produced offsite. Historically, the U.S. and Canada have relied heavily on countries such as China, India and Italy to supply these ingredients in a timely and economic manner. But the pandemic fueled a need to produce active pharmaceutical ingredients (APIs) domestically to »

China's Pharmaceutical Capacity Remains Strong Despite COVID-Related Downturn

Researched by Industrial Info Resources (Sugar Land, Texas)--According to China's National Bureau of Statistics, in 2019, China's pharmaceutical capacity reached 2.769 million tons, with a year-over-year growth of 20.2%. In 2020, capacity was 2.734 million tons, a slight downturn attributed to the COVID-19 pandemic. The annual output of China's active pharmaceutical ingredients (APIs) stabilized at about »

COVID-19 Pandemic Increases Demand for Vaccine Delivery Devices

Researched by Industrial Info Resources (Sugar Land, Texas)--As companies continue to develop vaccines to combat the pandemic, there is a growing need for needles, syringes and other vaccine delivery devices. Companies like Apiject and Becton and Dickenson (BD) are investing millions to produce the ancillary equipment needed for the vaccines. Apiject is investing nearly a billion dollars for a »